Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2022 · 10-Q
Revenue$7.68M$7.68M+2.4% vs Q3 2021 Net Income$466.82K$466.82K−45.5% vs Q3 2021 EPS Diluted$0.06$0.06−40.0% vs Q3 2021 Operating Income$954,311−40.2% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$8,549,921N/M Margins · derivedOperating margin12.4%−8.8 pt vs Q3 2021
Net margin6.1%−5.3 pt vs Q3 2021
ended Aug 31, 2022 · filed Oct 18, 2022 · 48 d after period end